Segment & Geographic Data Quant-Grade Normalized (live API) API & CSV Delivery

Schrodinger Inc's Business Segments

Schrodinger Inc's reported revenue by business segment and by geographic region, quarterly and annual, normalized against the consolidated income statement. Free below: the top 3 rows per table, this quarter and this fiscal year. Subscriber access adds the full segment history and operating income by segment.

Segment Data As of Q1 FY2026
Reportable Segments
2
Per the company's own filing, this quarter
Largest Segment
Software
60.7% of revenue
Total Revenue
$ 59
Consolidated, this quarter
Regions Reported
3
Geographic regions, this quarter
API endpoints for this dataset
https://api.csimarket.com/api/v1/companies/SDGR/segments
https://api.csimarket.com/api/v1/companies/SDGR/geographic
https://api.csimarket.com/api/v1/companies/SDGR/exposure
Programmatic access for models, analytics, and integration workflows.
Pull these exact ratios programmatically
Dataset & schema
https://api.csimarket.com/api/datasets/business_segments
https://api.csimarket.com/api/schema/business_segments
https://api.csimarket.com/api/meta/business_segments

Revenue Share by Reportable Segment - Q1 FY2026

61%largest
  • Software60.7%
  • Drug discovery39.3%

Revenue by Reportable Segment - Q1 FY2026

SegmentPeriodRevenue
(Millions)
% of TotalOperating Income
SoftwareQ1 FY2026$ 3660.7%-
Drug discoveryQ1 FY2026$ 2339.3%-

Revenue Share by Region - Q1 FY2026

34%largest
  • EMEA34.4%
  • APAC11.4%
  • Non-US0.6%

Revenue by Geographic Region - Q1 FY2026

RegionPeriodRevenue
(Millions)
% of Total
EMEAQ1 FY2026$ 2034.4%
APACQ1 FY2026$ 711.4%
Non-USQ1 FY2026$ 00.6%

Revenue by Product & Service Category - Q1 FY2026

39%largest
  • Drug discovery39.1%
  • On Premise Software24.2%
  • Hosted software20.6%
  • Drug Discovery Services20%
  • Maintenance11.4%
  • Professional services4.5%
  • Drug discovery contribution0.3%
  • Contribution0.1%
  • Software products and services0%

Revenue by Product & Service Category - Q1 FY2026

CategoryPeriodRevenue
(Millions)
% of Total
Drug discoveryQ1 FY2026$ 2339.1%
On Premise SoftwareQ1 FY2026$ 1424.2%
Hosted softwareQ1 FY2026$ 1220.6%

Product and service categories are a supplemental disclosure and are not required to sum to consolidated revenue or to the reportable segments above.

6 more categories available

Sign in to unlock the full Schrodinger Inc dataset.

Description of Schrodinger Inc

Schrodinger Inc is a leading computational chemistry and biophysics software company that was founded in 1990 by William Goddard III, Michael Levitt, and Peter Kollman. Schrodinger Inc is named after physicist Erwin Schrodinger, who was awarded the Nobel Prize in Physics in 1933 for his contribution to the development of quantum mechanics.

Schrodinger Inc is headquartered in New York City and has additional offices in Europe and Asia. The company is known for its state-of-the-art computational chemistry and biophysics software tools that enable scientists to accurately simulate and predict the behavior of molecules and other biological systems. These tools are used extensively in drug discovery, materials science, and development of biotechnology products.

The company's software platform, Schrodinger Suite, includes a range of software packages that help scientists perform a variety of tasks such as molecular dynamics simulations, ligand-based and structure-based drug design, and protein structure prediction. The software platform is also used to predict and understand the interactions of molecules with biological targets, allowing for more efficient drug discovery.

Schrodinger Inc has a diverse customer base, including academic and government research institutions, biotechnology and pharmaceutical companies, and chemical and materials manufacturers. The company's software tools have been used in several drug discovery projects that have led to the development of successful drugs, including the HIV protease inhibitor Saquinavir and the antipsychotic drug Aripiprazole.

Schrodinger Inc is also actively involved in scientific research and development. The company has a team of scientists who work on developing new software tools and applications, as well as collaborating with academic and industrial partners on various research projects.

Overall, Schrodinger Inc is a leading software company that has made significant contributions to the fields of computational chemistry and biophysics. The company's innovative software tools have played an important role in advancing drug discovery, materials science, and biotechnology, and will continue to be a major force in the scientific community for years to come.
Schrodinger, Inc. is a prominent player in the field of computational software and technology solutions, especially focused on molecular modeling and simulation applications. The companys offerings are specifically tailored for scientists, researchers, and developers across a variety of sectors, including pharmaceuticals, biotechnology, chemicals, materials science, and academia. Below is an extensive overview of the company’s segments, products, and services.

Segments

1. Discovery
The Discovery segment is fundamental to Schrodingers mission. It provides a comprehensive suite of computational modeling and simulation tools aimed at facilitating drug discovery and design. The tools within this segment include:
- Maestro: A sophisticated user interface that streamlines the setup and execution of molecular simulations, allowing users to visualize and manipulate molecular structures with ease.
- Glide: A cutting-edge molecular docking program that excels in predicting interactions between small molecules (drugs) and their target proteins, thereby assisting researchers in understanding binding affinities and optimizing lead compounds.
- Prime: A tool for protein structure refinement that uses advanced techniques to make predictions about protein-ligand interactions and optimize protein structures for better drug design.
- Jacques: A versatile molecular modeling program that supports a variety of computational chemistry applications, including conformational analysis and molecular mechanics.

2. Materials Science
Schrodinger’s Materials Science segment provides innovative tools aimed at advanced materials research. This segment encompasses:
- Materials Science Suite: A suite of software tools for predicting material properties and behavior. This includes modeling capabilities for various material types like metals, polymers, and composites. Key functionalities include performance predictions, interactive modeling, and property simulations geared towards optimizing materials for specific applications.
- Chemistry with a focus on physics: Utilizing first-principles calculations to make predictions about material properties, such as thermal conductivity and electrical characteristics.

3. Enterprise
The Enterprise segment is focused on providing solutions for organizations to handle extensive computational tasks efficiently. Key offerings include:
- LiveDesign: A collaborative platform that enhances project management and supports real-time communication among team members involved in computational research.
- Caelus: A high-performance cloud computing service that allows users to run complex simulations in a scalable and flexible environment, reducing the need for in-house computing infrastructure.

Products

1. Suite of Computational Modeling and Simulation Tools
Schrodinger offers an integrated suite of tools designed for various applications, including:
- Jaguar: A quantum mechanics software tool that performs electronic structure calculations to inform molecular design.
- QikProp: A predictive modeling tool that estimates the properties of bioactive compounds, aiding in the selection of leads during drug discovery.
- MacroModel: For modeling and simulating biomolecules, particularly large macromolecules such as proteins and nucleic acids, bridging the gap between small-molecule and macromolecular simulations.

2. High-Performance Computing Services
Providing cutting-edge computing resources, Schrodinger facilitates high-performance simulations:
- Cloud Computing Solutions: These resources support on-demand simulations, allowing researchers to access necessary computational power without the burden of maintaining extensive physical infrastructure. This also includes optimized workflow solutions to enhance efficiency.

Services

1. Drug Discovery Services
Schrodinger’s drug discovery services are structured to expedite the drug development process for pharmaceutical and biotechnology firms. Services include:
- Computer-Aided Drug Design (CADD): Leveraging computational chemistry principles to design and optimize new therapeutic candidates.
- Structure-Based Design: Utilizing 3D structural data of targets to inform the design of new compounds.
- Molecular Dynamics Simulations: Providing insights into the dynamic behavior of proteins and ligands, crucial for understanding interactions.
- Free Energy Calculations: Assessing the energetics of molecular interactions, providing essential data for lead optimization.

2. Consulting Services
Schrodinger offers targeted consulting services to optimize research workflows. These services can include:
- Data Management Solutions: Advising on the best practices for handling large datasets generated during simulations and experiments.
- High-Throughput Screening: Implementing efficient methods to accelerate the screening of large libraries of compounds.
- Infrastructure Optimization: Helping clients transition their computational workloads to cloud environments for better resource management.

3. Training and Support
Recognizing the importance of user education, Schrodinger provides:
- Training Programs: Tailored online courses and seminars designed to familiarize users with their tools and enhance user proficiency.
- User Support: Dedicated customer support aimed at troubleshooting and ensuring users maximize the utility of Schrodingers tools, including personalized assistance based on specific needs.

In summary, Schrodinger, Inc. encompasses a holistic approach to computational modeling and simulation, with an extensive array of products and services that cater to diverse scientific needs. The company remains committed to innovating and providing solutions that enhance the efficiency, accuracy, and effectiveness of research across various fields.